Project Number 4R44AG071388-02 Agency/Funding Organization NIA Funding Year 2021 View Full Project Details for Development of a stress kinase inhibitor therapeutic candidate for Alzheimer's Disease and related dementia Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) f. Inflammation Researcher and Organization Principal Investigator ANDERSON, WAYNE F Principal Investigator First Name WAYNE F Principal Investigator Last Name ANDERSON Awardee Organization NEUROKINE THERAPEUTICS, LLC Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement PA-19-273: PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required FY Overall Cost $1,175,175 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M
